Patents by Inventor Daylen Aguilar Noriega

Daylen Aguilar Noriega has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF SYNTHETIC PEPTIDE FOR THE INDUCTION OF ANTITUMOR AND ANTIVIRAL IMMUNITY
    Publication number: 20240082392
    Abstract: Use of the peptide identified as SEQ ID NO: 1 for manufacturing a medicine which induces antitumor and antiviral immunity by immunogenic cell death. The invention also provides a method for treating cancer or viral infections by using therapeutically effective amounts of a drug that comprises the synthetic peptide of the invention. This method induces antitumor and antiviral immunity by immunogenic cell death. Also, the invention comprises the pharmaceutical combination of the peptide identified as SEQ ID NO: 1 and cancer immunotherapy approaches, which achieve stronger immunotherapeutic management to combat this disease.
    Type: Application
    Filed: November 23, 2021
    Publication date: March 14, 2024
    Inventors: Daylen AGUILAR NORIEGA, Silvio Ernesto PEREA RODRÍGUEZ, Yasser PERERA NEGRÍN, Dania, Marcia VÁZQUEZ BLOMQUIST, Gilda, Enrique LEMOS PÉREZ, Idania, Caridad BALADRÓN CASTRILLO, Pablo, Arsenio DÍAZ REYES
  • Chimeric vaccine antigens against hepatitis C virus
    Patent number: 9676825
    Abstract: The invention relates to chimeric vaccine antigens against hepatitis C virus (HCV) comprising selected regions of different antigens of said virus, which are placed in a pre-determined order inside the polypeptide. In addition, said chimeric antigens can include artificially formed specific epitopes for auxiliary T helper lymphocytes. The chimeric antigens and the resulting vaccine compositions are suitable for use in medicine and the pharmaceutical industry, as well as being suitable for prophylactic and/or therapeutic use against HCV. The vaccine compositions of the invention generate a powerful, broad-spectrum immune response against different antigens of the virus, with a minimum number of components.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: June 13, 2017
    Assignee: CENTRO DE INGENIERIA GENETICA Y BIOTECHNOLOGIA
    Inventors: Santiago Dueñas Carrera, Daylen Aguilar Noriega, Yalena Amador Cañizares, Liz Alvarez-Lajonchere Ponce de León, Gillian Martínez Donato, Sonia Gonzalez Blanco
  • CHIMERIC VACCINE ANTIGENS AGAINST HEPATITIS C VIRUS
    Publication number: 20150307558
    Abstract: The invention relates to chimeric vaccine antigens against hepatitis C virus (HCV) comprising selected regions of different antigens of said virus, which are placed in a pre-determined order inside the polypeptide. In addition, said chimeric antigens can include artificially formed specific epitopes for auxiliary T helper lymphocytes. The chimeric antigens and the resulting vaccine compositions are suitable for use in medicine and the pharmaceutical industry, as well as being suitable for prophylactic and/or therapeutic use against HCV. The vaccine compositions of the invention generate a powerful, broad-spectrum immune response against different antigens of the virus, with a minimum number of components.
    Type: Application
    Filed: October 28, 2013
    Publication date: October 29, 2015
    Inventors: Santiago Dueñas Carrera, Daylen Aguilar Noriega, Yalena Amador Cañizares, Liz Alvarez-Lajonchere Ponce de León, Gillian Martínez Donato, Sonia Gonzalez Blanco